Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Albany, NY, March 11, 2016 -- According to a latest study by Transparency Market Research (TMR), the global interventional cardiology devices market will firmly remain on the growth track thanks to the rising incidence of coronary artery disease, but the impact of this growth will be softened to some degree by a decrease in the average selling price of stents, a key product in the market. The report, published under the title, “Interventional Cardiology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022," by Transparency Market Research, finds that the market’s valuation was US$8.7 bn in 2013, and will rise to US$11.2 bn by 2022, at a 2.9% CAGR through the forecast period.
“For the most part, the growth of the interventional cardiology devices market will result organically via regular product launches and innovative improvements to existing products”, says a senior TMR analyst.The report segments the global interventional cardiology devices market on the basis of product type and criteria. Based on product type, the market has been segmented into: percutaneous transluminal coronary angioplasty (PTCA) balloons, catheters, stents, percutaneous transluminal coronary angioplasty (PTCA) guidewires, interventional cardiology systems, and other accessories.
Avail a Sample PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=853
In 2013, the stents formed the largest product segment in the global interventional cardiology devices market, thanks to the appreciable share held by drug eluting stents in the global market. For the purpose of an in-depth analysis, the report segments stents into drug eluting stents, bare metal stents, and bio-absorbable vascular stents.
Drug eluting stents represented the largest share in the market for interventional cardiology devices worldwide in 2013. Until 2022, the drug eluting stents segment is expected to remain in the leading position in the interventional cardiology devices market by product type based on the former’s demonstrated positive patient outcomes. However, the DES segment is expected to lose market share owing to the growing popularity of bio-absorbable stents. Bioabsorbable vascular stents will report the fastest growth rate over the forecast period given their ability to prevent complications such as late-stent and in-stent restenosis.
Browse Research Article:http://www.transparencymarketresearch.com/article/interventional-cardiology-devices.htm
Although this will slow down the growth rate of the DES segment, it will still continue to remain in a dominant position. Improved patient outcomes of drug eluting stents will remain the key factor fuelling their uptake.The catheters segment is sub-segmented into guiding catheters, angiography catheters, intravascular ultrasound (IVUS) catheters, and pulmonary artery catheters. The PTCA balloons segment is sub-segmented into scoring balloons, normal balloons, cutting balloons, and drug-eluting balloons. The report analyzes the largest and fastest-growing sub-segments under each of these segments.
Company profiles of leading market players form a crucial part of the report, especially for clients wanting to track the competition. For this purpose, the following companies have been profiled based on details such as product pipeline, recent M&A activity, financial status, and a SWOT analysis: St. Jude Medical, Inc., Abbott Laboratories, Inc., Terumo Medical Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Cordis Corporation, Cook Medical, Medtronic, plc, and Smiths Medical.
Interact with our Pool of Experienced Analysts for any Report Related Queries http://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=853
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr.Sudip.S 90 State Street, Suite 700 Albany, NY 12207 United States. Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/
